Telmisartan and stroke reduction in the ONTARGET trial: Benefit beyond blood pressure lowering?

Victor L. Serebruany, Dan Atar, Dan F. Hanley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)563-564
Number of pages2
JournalCerebrovascular Diseases
Issue number5
StatePublished - Nov 2008

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this